Definitive Healthcare Cor... (DH)
Definitive Healthcare Statistics
Share Statistics
Definitive Healthcare has 112.91M shares outstanding. The number of shares has increased by -4.26% in one year.
Shares Outstanding | 112.91M |
Shares Change (YoY) | -4.26% |
Shares Change (QoQ) | -2.26% |
Owned by Institutions (%) | 90.22% |
Shares Floating | 41.01M |
Failed to Deliver (FTD) Shares | 511 |
FTD / Avg. Volume | 0.05% |
Short Selling Information
The latest short interest is 2.1M, so 1.82% of the outstanding shares have been sold short.
Short Interest | 2.1M |
Short % of Shares Out | 1.82% |
Short % of Float | 4.64% |
Short Ratio (days to cover) | 5.53 |
Valuation Ratios
The PE ratio is undefined and the forward PE ratio is 17. Definitive Healthcare's PEG ratio is undefined.
PE Ratio | undefined |
Forward PE | 17 |
PS Ratio | 1.9 |
Forward PS | 1.3 |
PB Ratio | 0.79 |
P/FCF Ratio | undefined |
PEG Ratio | undefined |
Enterprise Valuation
Definitive Healthcare Corp. has an Enterprise Value (EV) of 1.26B.
EV / Earnings | -3.04 |
EV / Sales | 4.99 |
EV / EBITDA | -2.22 |
EV / EBIT | -1.77 |
EV / FCF | 21.61 |
Financial Position
The company has a current ratio of 2.3, with a Debt / Equity ratio of undefined.
Current Ratio | 2.3 |
Quick Ratio | 2.3 |
Debt / Equity | undefined |
Total Debt / Capitalization | 1.62 |
Cash Flow / Debt | 5.82 |
Interest Coverage | undefined |
Financial Efficiency
Return on equity (ROE) is -0.68% and return on capital (ROIC) is -85.05%.
Return on Equity (ROE) | -0.68% |
Return on Assets (ROA) | -0.38% |
Return on Capital (ROIC) | -85.05% |
Revenue Per Employee | $322,508.95 |
Profits Per Employee | $-528,291.56 |
Employee Count | 782 |
Asset Turnover | 0.23 |
Inventory Turnover | n/a |
Taxes
Income Tax | -42.3M |
Effective Tax Rate | 0.07 |
Stock Price Statistics
The stock price has increased by -64% in the last 52 weeks. The beta is 1.51, so Definitive Healthcare's price volatility has been higher than the market average.
Beta | 1.51 |
52-Week Price Change | -64% |
50-Day Moving Average | 4.04 |
200-Day Moving Average | 4.45 |
Relative Strength Index (RSI) | 36.48 |
Average Volume (20 Days) | 977.13K |
Income Statement
In the last 12 months, Definitive Healthcare had revenue of 252.2M and earned -413.12M in profits. Earnings per share was -3.54.
Revenue | 252.2M |
Gross Profit | 197.47M |
Operating Income | -710.82M |
Net Income | -413.12M |
EBITDA | -567.24M |
EBIT | -710.82M |
Earnings Per Share (EPS) | -3.54 |
Balance Sheet
The company has 105.38M in cash and 9.99M in debt, giving a net cash position of 95.38M.
Cash & Cash Equivalents | 105.38M |
Total Debt | 9.99M |
Net Cash | 95.38M |
Retained Earnings | -610K |
Total Assets | 1.09B |
Working Capital | 209.01M |
Cash Flow
In the last 12 months, operating cash flow was 58.2M and capital expenditures 0, giving a free cash flow of 58.2M.
Operating Cash Flow | 58.2M |
Capital Expenditures | 0 |
Free Cash Flow | 58.2M |
FCF Per Share | 0.5 |
Margins
Gross margin is 78.3%, with operating and profit margins of -281.85% and -163.81%.
Gross Margin | 78.3% |
Operating Margin | -281.85% |
Pretax Margin | -251.28% |
Profit Margin | -163.81% |
EBITDA Margin | -224.92% |
EBIT Margin | -281.85% |
FCF Margin | 23.08% |
Dividends & Yields
DH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -122.92% |
FCF Yield | 17.87% |
Analyst Forecast
The average price target for DH is $5, which is 73.6% higher than the current price. The consensus rating is "Hold".
Price Target | $5 |
Price Target Difference | 73.6% |
Analyst Consensus | Hold |
Analyst Count | 11 |
Scores
Altman Z-Score | -1.6 |
Piotroski F-Score | 7 |